The global rapid infuser market, valued at $796.9 million in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $1,109 million by 2031, as per a recent report ...

As the healthcare industry continues shifting toward decentralized, patient-centric care models, home infusion and specialty pharmacy services are gradually becoming key battlegrounds for growth. In ...

Chapter 19 – Oceania Rapid infuser Market Analysis 2015-2019 and Forecast 2020-2030 This chapter consists of important parameters that have a huge impact on the growth of the Rapid infuser market in ...

Belmont Instrument Corporation has announced that The Belmont® Rapid Infuser, a blood and vital fluid warmer, FDA cleared in 1999, has now been used in over 350,000 procedures worldwide. This ...

A recent market study published by Future Market Insights (FMI) on the Rapid infuser market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030.The report consists of ...

CORPUS CHRISTI, Texas — The life saving infusion therapy used to prevent COVID-19 patients from ending up in the hospital is no longer available through the State.

Life-saving innovations Cleared by the FDA over twenty years ago, the Belmont Rapid Infuser was vitally important for Boston Marathon victims.

In their analysis of 269 rapid infusions of natalizumab and 100 rapid infusions of ocrelizumab, there were two infusion-related reactions in the natalizumab group and eight in the ocrelizumab group.

Rapid City's only indoor shooting range gets approval from the Planning Commission, but still no open date.

MACON, Ga.--(BUSINESS WIRE)--Smisson-Cartledge Biomedical LLC, an ISO 13485:2016 certified manufacturer of the ThermaCor 1200 Rapid Infuser technology for use in a broad spectrum of medical ...